RBN-2397, a novel, potent, and selective PARP7 inhibitor, induces tumor-intrinsic type I interferon responses and adaptive immunity in patient tumorsKristy Kuplast-Barr,Melissa L. Johnson,Manish R. Patel,Timothy A. Yap,Gerald S. Falchook,Patricia LoRusso,Ryan Abo,Chang Liu, Erika L. Manyak,Lisa Cleary,Viviana Bozon,Sudha Parasuraman,Heike Keilhack,Kristen McEachernCANCER RESEARCH(2022)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要